Your browser doesn't support javascript.
loading
Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty.
Akkerhuis, K M; van Den Brand, M J; van Der Zwaan, C; Peels, H O; Suryapranata, H; van Der Wieken, L R; Stibbe, J; Hoffmann, J; Baardman, T; Deckers, J W; Simoons, M L.
Affiliation
  • Akkerhuis KM; Thoraxcenter, Erasmus University and University Hospital Rotterdam, Netherlands. makkerhuis@cardialysis.nl
Heart ; 85(4): 444-50, 2001 Apr.
Article in En | MEDLINE | ID: mdl-11250974
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidines / Biphenyl Compounds / Platelet Aggregation Inhibitors / Prodrugs / Angioplasty, Balloon, Coronary / Platelet Glycoprotein GPIIb-IIIa Complex / Coronary Disease Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Heart Journal subject: CARDIOLOGIA Year: 2001 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidines / Biphenyl Compounds / Platelet Aggregation Inhibitors / Prodrugs / Angioplasty, Balloon, Coronary / Platelet Glycoprotein GPIIb-IIIa Complex / Coronary Disease Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Heart Journal subject: CARDIOLOGIA Year: 2001 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom